Anlotinib combined with mXELIRI as second-line treatment in advanced colorectal cancer pretreated with bevacizumab plus standard chemotherapy: A single-arm, phase IB/II study

被引：0
|
作者：
Qu, Xin
Chen, Xian
Li, Yong
Liu, Li-rong
Qu, Yan-chun
Hou, Fang-fang
Li, Wen-zhu
Liu, Yi-hong
Zhu, Yan-juan
Zhang, Haibo
机构：
[1] Guangdong Prov Hosp Chinese Med, Dept Oncol, Guangzhou, Peoples R China
[2] Guangdong Prov Hosp Chinese Med, Guangzhou, Peoples R China
[3] Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China
[4] Guangdong Prov Hosp Tradit Chinese Med, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.TPS220
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS220
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Comparative analysis of the effectiveness of second-line bevacizumab plus chemotherapy in second-line therapy in metastatic colorectal cancer.
    Smagulova, Kaldigul
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [42] Anlotinib combined with carboplatin/paclitaxel and maintenance anlotinib as front-line treatment for newly diagnosed advanced ovarian cancer: A phase II, single-arm, multicenter study (ALTERGO-010)
    Cheng, Wenjun
    Jiang, Yi
    Gao, Yingchun
    Chen, Youguo
    Cai, Yunlang
    Zhou, Huaijun
    Xue, Jinling
    Yu, Jinjin
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S77 - S78
  • [43] A phase II trial of anlotinib combined chemotherapy as second-line and above therapy in HER2-negative advanced breast cancer
    Yuan, Yuan
    Zhang, Lili
    Xu, Ting
    Xiong, Weili
    Hu, Sainan
    Huang, Jiayuan
    Dong, Min
    Xu, Xinyu
    Lou, Kexin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] A phase Ib single-arm study of bintrafusp alfa for the treatment of pretreated, locally advanced/unresectable or metastatic urothelial cancer.
    Grivas, Petros
    Morales-Barrera, Rafael
    Sridhar, Srikala S.
    Loriot, Yohann
    Van der Heijden, Michiel Simon
    Galsky, Matt D.
    Baxter, Dawn
    Khaled, Ahmed Hussein
    Hug, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [45] Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study
    Cardone, C.
    De Stefano, A.
    Rosati, G.
    Cassata, A.
    Silvestro, L.
    Borrelli, M.
    Di Gennaro, E.
    Romano, C.
    Nappi, A.
    Zanaletti, N.
    Foschini, F.
    Casaretti, R.
    Tatangelo, F.
    Lastoria, S.
    Raddi, M.
    Bilancia, D.
    Granata, V.
    Setola, S.
    Petrillo, A.
    Vitagliano, C.
    Gargiulo, P.
    Arenare, L.
    Febbraro, A.
    Martinelli, E.
    Ciardiello, F.
    Delrio, P.
    Budillon, A.
    Piccirillo, M. C.
    Avallone, A.
    ESMO OPEN, 2023, 8 (01)
  • [46] Phase II study of biweekly irinotecan and cisplatin as second-line chemotherapy in pretreated patients with advanced gastric cancer.
    Baek, JH
    Kim, JG
    Sohn, SK
    Song, HS
    Kwon, KY
    Do, YR
    Ryu, HM
    Bae, SH
    Park, GW
    Lee, KH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 325S - 325S
  • [47] Anlotinib plus tislelizumab combined with chemotherapy as neoadjuvant treatment in triple-negative breast cancer: A prospective, single-arm, open-label phase II study.
    Luo, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [48] Efficacy and safety of fruquintinib plus investigator's choice of chemotherapy as second-line therapy in metastatic colorectal cancer: A multicenter, single-arm phase 2 trial
    Zhao, Wensi
    Li, Liping
    Huang, Junping
    Li, Jun
    Gong, Wei
    He, Lilin
    Chen, Yuan
    Wang, Songlin
    Yu, Xiongjie
    Han, Qi
    Ke, Shaobo
    Shi, Wei
    Chen, Yongshun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Biweekly irinotecan and cisplatin as second-line chemotherapy in pretreated patients with advanced gastric cancer: A multicenter phase II study
    Baek, JH
    Kim, JG
    Sohn, SK
    Kim, DH
    Lee, KB
    Song, HS
    Kwon, KY
    Do, YR
    Ryoo, HM
    Bae, SH
    Park, KU
    Kim, MK
    Lee, KH
    Hyun, MS
    Chung, HY
    Yu, W
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2005, 20 (06) : 966 - 970
  • [50] A phase II study of antiangiogenic therapy (Apatinib) plus chemotherapy as second-line treatment in advanced small cell lung cancer
    Xu, Yinghui
    Wang, Xu
    Sun, Chao
    Gao, Zhiru
    He, Hua
    Qiu, Shi
    Guo, Ye
    Ma, Xiaohui
    Song, Junya
    Ma, Kewei
    CANCER MEDICINE, 2023, 12 (03): : 2979 - 2989
12345